drugset / Trial / NCT06003101

Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies

NCT06003101

Phase 3 Recruiting 160 enrolled Massachusetts General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?

Timeline

Start
2023-08-30
Primary completion
2027-08-30
Completion
2045-08-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bone Marrow Aspirate Concentrate Cell therapy

Indications

No indication recorded.